02 febbraio 2018 Radioterapia

Mitchell Cancer Institute, US, selects RayStation for TomoTherapy

The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Alabama, has selected RayStation* as its treatment planning system for the TomoTherapy ® System. The center also treats patients using a CyberKnife ®System and will use RayStation* for this in the future.

MCI’s radiation therapy service is equipped with state-of-the-art Accuray´s CyberKnife and TomoTherapy System, as well as a 64-slice PET-CT scanner. The center was initially interested in RayStation’s forthcoming support for the CyberKnife System, but quickly saw that the system could meet all of its treatment planning needs into the future, including the TomoTherapy System.

Dr. Weisi Yan, Director of the CyberKnife Program at MCI, says: “We were very impressed by the capabilities and user-friendliness of RayStation. As a leading-edge treatment center, we need the best possible technology in order to deliver outstanding care and maximize efficiency. RayStation will help us to achieve our goals.”

Hal Hopper, Manager of MCI’s Department of Radiation Oncology, says: “RayStation is fast and effective in planning treatments for all possible techniques we are likely to offer. It is much less labor-intensive than other systems we have used. With RayStation, the physician can choose the best course of treatment more quickly.”

Johan Löf, CEO of RaySearch, says: “MCI shares our vision of continuously advancing cancer treatment. We are very pleased to be able to meet their requirements for advanced clinical techniques as well as optimized workflows and use of resources.”
    

 

About MCI
Founded in 2000, MCI provides cancer treatment in three locations: MCI headquarters in Mobile, the MCI Kilborn Clinic in Fairhope and Monroe County Hospital in Monroeville. The center’s researchers and clinicians focus daily on the battle against cancer serving a potential catchment population of more 4.1 million people, with a singular focus of advancing cancer diagnosis, treatment and prevention in the region and beyond. Since its establishment, the center’s strategic goal has remained constant: to achieve competitiveness for future designation as an NCI Comprehensive Cancer Center and to achieve self-sustaining, long-term financial viability.

News

17/04/2018 News

Machine Learning and latest RayCare innovations on show at ESTRO 37

Machine Learning and latest RayCare innovations on show at ESTRO 37 During 20–24 April, RaySearch will be exhibiting at the ESTRO 37 congress in Barcelona, Spain. In addition to the latest advances in machine le [...]

16/04/2018 News

RaySearch and IBA to demonstrate first online adaptive proton workflow at ESTRO

RaySearch, the global leader in software for cancer treatment, and IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, will make a unique joint presentation at the ESTRO 37 [...]

10/04/2018 Radioterapia

RayStation selected for Proton and Carbon Ion Therapy centers in Heidelberg and Marburg, Germany

RayStation* has been chosen as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT) and Marburg Ion Beam Therapy Center (MIT) – The new order means that all carbon ion therapy centers in Eu [...]

Eventi

20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

20apr2018 | Eventi

ESTRO 37, Barcellona 20-24 April 2018

Tecnologie Avanzate sarà sponsor del prossimo ESTRO 37 che avrà luogo a Barcellona dal 20 al 24 aprile 2018

Video gallery